Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Ecoza

(Econazole nitrate plus Benzydamine HCl pessary)

Small molecule

0

Indications

1

Total Trials

0

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

1

Patents

Clinical

Trials by Indication[1]

ESS1 trial

Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary

Completed·AAziende Chimiche Riunite Angelini Francesco S.p.A·Phase 1·NCT02720783·49 enrolled

Regulatory

FDA Approval Timeline[3]

Dec 23, 1982

SPECTAZOLE

NDA NDA018751

Oct 24, 2013

ECOZA

NDA NDA205175

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Econazole nitrate plus Benzydamine HCl pessary. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Econazole nitrate plus Benzydamine HCl pessary compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA205175). U.S. Food & Drug Administration.
[4]
FDA Orange Book — Patent and exclusivity data for Ecoza. U.S. Food & Drug Administration.
[5]
SEC EDGAR — Alvogen Korea company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: AAlvogen Korea

Patent Landscape[4]

Patent Cliff

Aug 8, 2031

Earliest patent expiration — generic entry possible after this date

Patent #Expires

10071054Aug 8, 2031

Related News